Get the Stockscreener App
14.18
1.12%
-0.16
After Hours:
14.19
0.010
+0.07%
Stevanato Group Spa stock is traded at $14.18, with a volume of 344.38K.
It is down -1.12% in the last 24 hours and down -7.32% over the past month.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.
See More
Previous Close:
$14.34
Open:
$14.34
24h Volume:
344.38K
Relative Volume:
0.56
Market Cap:
$3.87B
Revenue:
$1.35B
Net Income/Loss:
$159.12M
P/E Ratio:
24.32
EPS:
0.5831
Net Cash Flow:
$12.86M
1W Performance:
-6.89%
1M Performance:
-7.32%
6M Performance:
-43.51%
1Y Performance:
-32.83%
1-Day Range:
$14.18
$14.92
1-Week Range:
$14.18
$15.55
52-Week Range:
$13.91
$28.00
Stevanato Group Spa Stock (STVN) Company Profile
Name
Stevanato Group Spa
Sector
Industry
Phone
-
Address
-
Compare STVN vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STVN
Stevanato Group Spa
|
14.18 | 3.91B | 1.35B | 159.12M | 12.86M | 0.5831 |
ISRG
Intuitive Surgical Inc
|
469.98 | 167.61B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
158.27 | 44.35B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
75.26 | 36.19B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
42.67 | 34.11B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
226.31 | 33.24B | 5.40B | 1.49B | 1.78B | 10.12 |
Stevanato Group Spa Stock (STVN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Resumed | Morgan Stanley | Equal-Weight |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Dec-03-24 | Resumed | Morgan Stanley | Equal-Weight |
| Apr-22-24 | Initiated | Exane BNP Paribas | Outperform |
| Nov-01-23 | Downgrade | Jefferies | Buy → Hold |
| Sep-26-23 | Initiated | Stephens | Overweight |
| Sep-19-23 | Initiated | CJS Securities | Market Outperform |
| Aug-24-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-10-21 | Initiated | BofA Securities | Buy |
| Aug-10-21 | Initiated | Citigroup | Buy |
| Aug-10-21 | Initiated | Jefferies | Buy |
| Aug-10-21 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-10-21 | Initiated | Morgan Stanley | Overweight |
| Aug-10-21 | Initiated | Wells Fargo | Overweight |
View All
Stevanato Group Spa Stock (STVN) Latest News
Director Luciano Santel lists 1,787 Stevanato Group (STVN) shares held - Stock Titan
Stevanato Group (STVN) director Elisabetta Magistretti submits initial Form 3 - Stock Titan
Profit Recap: Is Stevanato Group SpA stock a value trap2026 Analyst Calls & Fast Gain Swing Alerts - baoquankhu1.vn
Fill Finish Manufacturing Market to See Booming Growth 2026-2033 | Stevanato Group, OPTIMA, SGD Pharma - openPR.com
Returns Recap: What are analysts price targets for Stevanato Group SpA2026 Technical Patterns & Expert Verified Movement Alerts - baoquankhu1.vn
Stevanato Group S.P.A. (IT0005452658.SG) Stock Earnings Call Transcripts - Yahoo Finance
Stevanato Group S.p.A (NYSE:STVN) Q4 2025 earnings call transcript - MSN
Stevanato Group outlines 2026 revenue target up to €1.308B with high-value solutions set to reach 48% of sales - MSN
Behavioral Patterns of STVN and Institutional Flows - Stock Traders Daily
STVN PE Ratio & Valuation, Is STVN Overvalued - Intellectia AI
[Form 3] Stevanato Group S.p.A. Initial Statement of Beneficial Ownership - Stock Titan
Director Karen Flynn reports Stevanato Group (NYSE: STVN) share stake - Stock Titan
Stevanato Group (STVN) director Federici discloses direct and indirect share holdings - Stock Titan
Director Morel discloses 33,942 Stevanato (STVN) Ordinary Shares in Form 3 - Stock Titan
Stevanato Group (NYSE: STVN) director files Form 3/A with no trades - Stock Titan
Director Lin Sue-Jean discloses 2,000-share stake in Stevanato (STVN) - Stock Titan
Stevanato Group (STVN) director reports holding 65,976 ordinary shares - Stock Titan
Stevanato Group (STVN) CFO discloses ordinary share and multi-year RSU holdings - Stock Titan
Stevanato (NYSE: STVN) director details 253M Class A share holding - Stock Titan
Stevanato Group (STVN) executive discloses 404,942 shares and multiple RSU grants - Stock Titan
Director Bonanni reports 119,700 Stevanato (NYSE: STVN) shares - Stock Titan
Meme Stocks: Should value investors consider Stevanato Group SpA2026 Final Week & Weekly Hot Stock Watchlists - baoquankhu1.vn
Can Stevanato Group SpA deliver consistent EPS growth2026 Valuation Update & Entry Point Confirmation Signals - baoquankhu1.vn
Stevanato Group S.P.A. (IT0005452658.SG) Stock Price, News, Quote & History - Yahoo Finance
Here’s Why Artisan Small Cap Fund Remains Invested in Stevanato Group (STVN) - Insider Monkey
Fred Alger Management LLC Reduces Stock Position in Stevanato Group S.p.A. $STVN - MarketBeat
Stevanato secures €200M in financing - MSN
Stevanato Group shares jump nearly 17% after strong fourth-quarter results - MSN
Income Plays: Is Stevanato Group SpA a good ESG investmentMarket Trend Report & Accurate Intraday Trade Tips - baoquankhu1.vn
Stevanato Group S.p.A. $STVN Shares Bought by Bamco Inc. NY - MarketBeat
Stevanato Group: Riding The Biologics Boom—Can Its Injectable Solutions Become The Backbone Of Next-Gen Drug Delivery? - Smartkarma
Stevanato Group S.p.A. (NYSE:STVN) Sees Significant Decline in Short Interest - MarketBeat
KeyBanc cuts Stevanato Group stock price target on GLP-1 outlook - Investing.com Nigeria
Top Stevanato Group (STVN) Competitors 2026 - MarketBeat
Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum - The National Law Review
Stevanato Group Posts 2025 Growth on High-Value Syringes and GLP‑1 Demand - The Globe and Mail
Earnings Miss: Can Stevanato Group SpA keep up with sector leadersWeekly Trend Recap & Expert Verified Movement Alerts - baoquankhu1.vn
[6-K] Stevanato Group S.p.A. Current Report (Foreign Issuer) | STVN SEC FilingForm 6-K - Stock Titan
(STVN) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Stevanato Group S.p.A. 2025 Q4ResultsEarnings Call Presentation (NYSE:STVN) 2026-03-10 - Seeking Alpha
Stevanato Group SpA (STVN) Trading 3.05% Higher on Mar 9 - GuruFocus
Stevanato Group Earnings Call Highlights High-Value Surge - TipRanks
Day Trade: Can Stevanato Group SpA keep up with sector leadersJuly 2025 Opening Moves & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Stevanato (STVN) Q4 2025 Earnings Call Transcript - AOL.com
Stevanato Group S.P.A. (IT0005452658.SG) Analyst Insights, Price Targets & Recommendations - Yahoo Finance
Morgan Stanley Has Lowered Expectations for Stevanato Group (NYSE:STVN) Stock Price - MarketBeat
KeyBanc Maintained Overweight for Stevanato Group S.p.A. (STVN) March 2026 - Meyka
Stevanato: Strong Q4 Results Reinforce Long-Term Growth Story - Seeking Alpha
Stevanato Group (NYSE:STVN) Margin Improvement To 12% Tests Bullish Earnings Narratives - Sahm
Stevanato Group Posts Record High‑Value Revenue and Strong 2025 Results, Sets Upbeat 2026 Outlook - The Globe and Mail
Stevanato Group Spa Stock (STVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.95%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):